Skip to content

Clinical trials

Phase 3 Myocardial Infarction trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 3 Country / region: Austria Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20051
20062
20081
20091
20111
20191
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Sanofi2
AstraZeneca1
Boehringer Ingelheim1
Centocor, Inc.1
Novo Nordisk A/S1
Stiftung Institut fuer Herzinfarktforschung1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction12
Stroke6
Cardiovascular Diseases4
Acute Coronary Syndrome2
Coronary Artery Disease2
Angina, Unstable1
Atherosclerosis1
Coronary Stenosis1
Diabetes Mellitus1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.